AAOS to Host Second Annual Biologics Symposium

This year, AAOS will host its second annual biologics symposium, titled “The Next Generation of Biologics: Use of Real-world Evidence,” in Washington, D.C. It is designed to convene experts in science and medicine, industry, as well as regulatory agencies to examine current real-world evidence as it pertains to musculoskeletal medicine.

ICL Elucidates Regulatory Guidelines on Orthobiologics

Patrick Daly

Scott Bruder, MD, PhD, founder and CEO of Bruder Consulting & Venture Group, was the first presenter in the Instructional Course Lecture (ICL) titled “Orthobiologics Use and Marketing: U.S. Food and Drug Administration, Federal Trade Commission, and Ethical Compliance,” which discussed the complex regulations surrounding the use of orthobiologics.